DCPH Market Cap History



Below is a table of the DCPH market cap history going back to 9/28/2017:

Date DCPH Market Cap
9/28/2017541.42M
10/31/2017625.43M
2/28/2018815.51M
4/30/2018731.41M
7/31/20181.30B
10/31/2018760.38M
2/28/20191.08B
4/30/2019878.35M
6/30/2019861.75M
9/30/20191.73B
2/28/20202.96B
4/30/20203.24B
7/31/20202.61B
10/30/20203.31B
1/31/20212.55B
4/30/20212.69B
7/30/20211.77B
10/29/20211.95B
1/31/2022493.60M
4/29/2022670.11M
7/29/2022847.97M
10/28/20221.17B
1/31/20231.29B
4/28/20231.12B
7/28/20231.05B
10/26/2023815.65M
1/31/20241.16B

Also see: DCPH Shares Outstanding History
and DCPH YTD Return
DCPH Historical Market Cap:
+12.71% CAGR
DCPH Historical Market Cap: +12.71% CAGR

Mouse over chart for data details
9/28/2017 ...1/31/2024
Deciphera Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing medicines to improve the lives of people with cancer. Using its proprietary switch-control kinase inhibitor platform and capabilities in kinase biology, Co. designs kinase inhibitors to target the switch pocket region of the kinase with the goal of developing medicines. QINLOCK, Co.'s switch-control kinase inhibitor, was developed using Co.'s proprietary drug discovery platform and developed for the treatment of fourth-line gastrointestinal stromal tumor. Co. has developed a pipeline of drug candidates, including vimseltinib and DCC-3116. We show 27 historical shares outstanding datapoints in our DCPH shares outstanding history coverage, used to compute DCPH market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing DCPH market cap history over the course of time is important for investors interested in comparing DCPH's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of DCPH versus a peer is one thing; comparing DCPH market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like DCPH can fluctuate over the course of history. With this page we aim to empower investors researching DCPH by allowing them to research the DCPH market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree DCPH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Deciphera Pharmaceuticals (DCPH) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

DCTH Market Cap History
DEPO Market Cap History
DERM Market Cap History
DFFN Market Cap History
DGX Market Cap History
DHR Market Cap History
DICE Market Cap History
DMK Market Cap History
DMPI Market Cap History
DMTK Market Cap History
More Healthcare companies »

 

DCPH Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.